Cargando…
Conivaptan: Evidence supporting its therapeutic use in hyponatremia
INTRODUCTION: The available treatment options for euvolemic and hypervolemic hyponatremia are limited, and consist mainly of fluid restriction, diuresis, or hypertonic solutions. Most of these therapies are neither well tolerated nor totally effective, and many are associated with significant advers...
Autores principales: | Li-Ng, Melissa, Verbalis, Joseph G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2899773/ https://www.ncbi.nlm.nih.gov/pubmed/20694067 |
Ejemplares similares
-
Conivaptan and its role in the treatment of hyponatremia
por: Ghali, Jalal K, et al.
Publicado: (2009) -
Conivaptan: a step forward in the treatment of hyponatremia?
por: Hline, Su Su, et al.
Publicado: (2008) -
Dose comparison of conivaptan (Vaprisol(®)) in patients with euvolemic or hypervolemic hyponatremia – efficacy, safety, and pharmacokinetics
por: Palmer, Biff F, et al.
Publicado: (2016) -
Efficacy of vaptans for correction of postoperative hyponatremia: A comparison between single intravenous bolus conivaptan vs oral tolvaptan
por: Rajan, Sunil, et al.
Publicado: (2018) -
The Effect of Intravenous Conivaptan on Intraocular Pressure
por: Krishnankutty, Saritha Valsala, et al.
Publicado: (2016)